Red Robin: Surprise Surprise Alibaba Group Holding Limited (BABA), CVS Health Corporation (CVS)?

Alibaba Group Holding Limited (NYSE:BABA) average daily volatility for this week is 3.01% which is less than the 3.69% recorded over the past month. Its shares dropped by -28.52% or -$60.38 from its last recorded high of $211.7 which it attained on May 06 to close at $151.32 per share. Over the past 52 weeks, the shares of Alibaba Group Holding Limited has been trading as low as $129.77 before witnessing a massive surge by 16.61% or $21.55. This price movement has led to the BABA stock receiving more attention and has become one to watch out for. It dipped by -0.24% on Sunday and this got the market worried. The stock’s beta now stands at 2.26 and when compared to its 200-day moving average and its 50-day moving average, BABA price stands -11.52% below and 3.02% above respectively.

Alibaba Group Holding Limited (BABA) rose 8.28% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a drop that has seen it decline -20.27% and is now up by 10.4% since start of this year. A look at its monthly performance shows that the stock has recorded a -0.34% fall over the past 30 days. Its equity price climbed by 9.42% over the past three months which led to its overall six-month decrease to stand at -20.43%.

Experts from research firms are bullish about the near-term performance of Alibaba Group Holding Limited with most of them predicting a $202.94 price target on a short-term (12 months) basis. The average price target by the analysts will see a 34.11% rise in the stock and would lead to BABA’s market cap to surge to $527.64B. The stock has been rated an average 1.7, which roughly stands towards the bullish end of the spectrum. Reuters looked into the 49 analysts that track Alibaba Group Holding Limited (NYSE:BABA) and find out that 1 of them rated it as a Hold. 48 of the 48 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.

A look at BABA technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 59.75 point. Its trading volume has lost -11000000 shares compared to readings over the past three months as it recently exchanged 9547125 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 20480000 shares, and this is 0.47 times the normal volume.

The price of CVS Health Corporation (NYSE:CVS) currently stands at $65.81 after it went up by $0.26 or 0.4% and has found a strong support at $64.84 a share. If the CVS price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $63.87 mark would also be bad for the stock as it means that the stock would plunge by 2.95% from its current position. However, if the stock price is able to trade above the resistance point around $66.3, then it could likely surge higher to try and break the upward resistance which stands at $66.79 a share. Its average daily volatility over the past one month stands at 3.24%. The stock has plunged by 2.2% from its 52-weeks high of $64.36 which it reached on Jan. 29, 2018. In general, it is 8.62% above its 52-weeks lowest point which stands at $60.14 and this setback was observed on Mar. 27, 2018.

Analysts have predicted a price target for CVS Health Corporation (CVS) for 1 year and it stands at an average $91.17/share. This means that it would likely increase by 38.54% from its current position. The current price of the stock has been moving between $64.36 and $65.82. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $71. On the other hand, one analyst is super bullish about the price, setting a target as high as $106.

The CVS stock Stochastic Oscillator (%D) is at 51.89%, which means that it is currently neutral. The shares P/S ratio stands at 0.45 which compares to the 18.11 recorded by the industry or the 6.26 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 8.73, which is lower than the 42.1 multiple of 12-month price-earnings (P/E). The company’s earnings have gone up, with a quarterly increase rate of 10.6% over the past five years.

Analysts view CVS Health Corporation (NYSE:CVS) as a Buy, with 1.9 consensus rating. Reuters surveyed 26 analysts that follow CVS and found that 6 of those analysts rated the stock as a Hold. The remaining 20 were divided, with 20 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying CVS Health Corporation (CVS) shares or sell it if they already own it.